MICA records charge due to proxy fight
Imaging services provider Medical Imaging Centers of America thismonth reported financial results for its first quarter (end-March)that showed the San Diego company taking a one-time $1.3 millioncharge related to its proxy battle with shareholder group
Imaging services provider Medical Imaging Centers of America thismonth reported financial results for its first quarter (end-March)that showed the San Diego company taking a one-time $1.3 millioncharge related to its proxy battle with shareholder group SteelPartners of New York City.
MICA had revenues for the quarter of $9.5 million, compared with$14.2 million in the same period last year. Much of the drop wasdue to MICA's sale of its ultrasound and nuclear medicine businessto Diagnostic Health Services last year.
MICA had net income of $312,000, compared with $924,000 in thefirst quarter of 1995. MICA took a special charge of $1.3 millionfor the Steel Partners battle and recorded a one-time gain of$382,000 related to debt forgiveness.
As part of the agreement that settled the Steel Partners proxyfight, MICA agreed to look for a corporate partner that wouldmerge with or acquire MICA (SCAN 3/27/96). MICA president andCEO Robert Muehlberg said that the company is focusing on findingsuch a partner and plans to make an announcement regarding itssearch on June 19.
What a New Mammography Study Reveals About BMI, Race, Ethnicity and Advanced Breast Cancer Risk
December 8th 2023In a new study examining population attributable risk proportions (PARPs) based on data from over three million screening mammography exams, researchers found that postmenopausal Black women had the highest BMI-related PARP and premenopausal Asian and Pacific Islander women had the highest breast density-related PARP for advanced breast cancer.
Study: Contrast-Enhanced Mammography Changes Surgical Plan in 22.5 Percent of Breast Cancer Cases
December 7th 2023Contrast-enhanced mammography detected additional lesions in 43 percent of patients and led to additional biopsies in 18.2 percent of patients, over half of whom had malignant lesions, according to a study of over 500 women presented at the recent Radiological Society of North America (RSNA) conference.
